BioCentury
ARTICLE | Clinical News

Cell culture-based pandemic influenza vaccine regulatory update

April 8, 2013 7:00 AM UTC

Vivalis S.A. (Euronext:VLS, Nantes, France) said Kaketsuken (formerly the Chemo-Sero-Therapeutic Research Institute) submitted an NDA to Japan's Ministry of Health, Labor and Welfare (MHLW) for a cel...